In focus · trending topic

Oberland Capital

1 stories · following the connections

Melinta Therapeutics Signs $90 Million Financing Agreement with Oberland Capital to Fund Baxdela™ Commercial Activities and Expansion into Additional Indications

By Nasdaq OMXJun 29, 2017, 1:56 PM UTC